SCHEDULE OF COMMON STOCK PURCHASE WARRANTS ISSUED AND OUTSTANDING (Details) - $ / shares |
9 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
|
| Equity [Abstract] | ||
| Warrants Outstanding, Beginning balance | 23,970,000 | 29,700,000 |
| Weighted Average Exercise Price, Beginning balance | $ 0.13 | $ 0.13 |
| Warrants, Granted | 750,000 | 1,000,000 |
| Weighted Average Exercise Price, Granted | $ 0.10 | $ 0.10 |
| Warrants, Expired | (10,285,000) | (6,730,000) |
| Weighted Average Exercise Price, Expired | $ 0.19 | $ 0.11 |
| Warrants Outstanding, Ending balance | 14,435,000 | 23,970,000 |
| Weighted Average Exercise Price, Ending balance | $ 0.09 | $ 0.13 |
| X | ||||||||||
- Definition Weighted average exercise price, expired. No definition available.
|
| X | ||||||||||
- Definition Warrants weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, granted. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|